Emerging molecular therapeutic targets for cholangiocarcinoma.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of hepatology"
DOI: 10.1016/j.jhep.2017.03.026
Abstract: Cholangiocarcinomas (CCAs) are diverse epithelial tumors arising from the liver or large bile ducts with features of cholangiocyte differentiation. CCAs are classified anatomically into intrahepatic (iCCA), perihilar (pCCA), and distal CCA (dCCA). Each subtype has… read more here.
Keywords: molecular therapeutic; therapeutic targets; cca; emerging molecular ... See more keywords
Cholangiocarcinoma: novel therapeutic targets
Sign Up to like & getrecommendations! Published in 2020 at "Expert Opinion on Therapeutic Targets"
DOI: 10.1080/14728222.2020.1733528
Abstract: ABSTRACT Introduction: Cholangiocarcinoma (CCA) is a liver cancer derived from the biliary tree with a less than 30% five-year survival rate. Early diagnosis of CCA is challenging and treatment options are limited. Some CCA patients… read more here.
Keywords: microenvironment; therapeutic targets; cca; cholangiocarcinoma novel ... See more keywords
Novel and emerging targets for cholangiocarcinoma progression: therapeutic implications
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Therapeutic Targets"
DOI: 10.1080/14728222.2022.2029412
Abstract: ABSTRACT Introduction Cholangiocarcinoma (CCA) is a heterogeneous group of aggressive biliary malignancies. While surgery and liver transplantation are the only potentially curative modalities for early-stage disease, limited options are available for most patients with incurable-stage… read more here.
Keywords: novel emerging; targets cholangiocarcinoma; cholangiocarcinoma progression; progression therapeutic ... See more keywords